Monday 25 May 2020
Home      All news      Contact us      India
oneindia.com - 2 days ago

First COVID-19 vaccine to reach phase I clinical trial is safe,induces immune response

Beijing, May 23: The first COVID-19 vaccine to reach phase I clinical trial is safe, well-tolerated, and capable of generating an immune response against the novel coronavirus in humans, says a new research published in The Lancet journal. According to the


Latest News
Hashtags:   

First

 | 

COVID

 | 

vaccine

 | 

reach

 | 

phase

 | 

clinical

 | 

trial

 | 

induces

 | 

immune

 | 

response

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources